The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Regorafenib

Australian Public Assessment Report

AusPAR

AusPAR: Regorafenib [PDF, 1010.92 KB]

AusPAR: Regorafenib [Word, 1.3 MB]

Attachment: Product Information: Regorafenib [PDF, 251.99 KB]

Attachment: Product Information: Regorafenib [Word, 151.55 KB]

Attachment: Extract from Clinical Evaluation Report: Regorafenib [PDF, 1.18 MB]

Attachment: Extract from Clinical Evaluation Report: Regorafenib [Word, 1.96 MB]

Device/Product Name

Stivarga

Active ingredients

Regorafenib

AusPAR Date

7 February 2014

Published

18 February 2014

Submission Number

PM-2012-02342-3-4

Submission Type

New chemical entity

Decision

Approved